Clinical Trial Update: Haemocomplettan® P During Elective Complex Cardiac Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial evaluating Haemocomplettan P for fibrinogen deficiency in complex cardiac surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrinogen Deficiency

Drugs mentioned

• Haemocomplettan P (fibrinogen concentrate)

Snippet

Sponsor: Isala | Conditions: Fibrinogen Deficiency in Complex Cardiac Surgery | Phase 2, Phase 3 | Status: COMPLETED